Walter M. Stadler to Leukemia, Myeloid, Acute
This is a "connection" page, showing publications Walter M. Stadler has written about Leukemia, Myeloid, Acute.
Connection Strength
0.121
-
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clin Cancer Res. 2014 Jan 15; 20(2):490-8.
Score: 0.072
-
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial. J Clin Oncol. 2008 Mar 20; 26(9):1532-6.
Score: 0.049